Acute cardiac disorder or pneumonia and concomitant presence of pulmonary embolism by Rohacek, Martin et al.
Acute Cardiac Disorder or Pneumonia and Concomitant
Presence of Pulmonary Embolism
Martin Rohacek1*, Zsolt Szucs-Farkas2, Carmen A. Pfortmu¨ller3, Heinz Zimmermann1,
Aristomenis Exadaktylos1
1Department of Emergency Medicine, Inselspital, University Hospital Bern, Bern, Switzerland, 2Department of Diagnostic, Interventional and Pediatric Radiology,
Inselspital, University Hospital Bern, Bern, Switzerland, 3Department of Internal Medicine, Inselspital, University Hospital Bern, Bern, Switzerland
Abstract
Purpose: To determine the frequency of apparent acute pulmonary embolism (PE) and of concomitant disease in computed
tomography pulmonary angiography (CTPA); to compare the frequency of PE in patients with pneumonia or acute cardiac
disorder (acute coronary syndrome, tachyarrhythmia, acute left ventricular heart failure or cardiogenic shock), with the
frequency of PE in patients with none of these alternative chest pathologies (comparison group).
Methods: Retrospective analysis of all patients who received a CTPA at the emergency department (ED) within a period of
four years and 5 months.
Results: Of 1275 patients with CTPA, 28 (2.2%) had PE and concomitant radiologic evidence of another chest disease; 3
more (0.2%) had PE and an acute cardiac disorder without radiological evidence of heart failure. PE was found in 11 of 113
patients (10%) with pneumonia, in 5 of 154 patients (3.3%) with an acute cardiac disorder and in 186 of 1008 patients (18%)
in the comparison group. After adjustment for risk factors for thromboembolism and for other relevant patient’s
characteristics, the proportion of CTPAs with evidence of PE in patients with an acute cardiac disorder or pneumonia was
significantly lower than in the comparison group (OR 0.13, 95% CI 0.05–0.33, p,0.001 for patients with an acute cardiac
disorder, and OR 0.45, 95% CI 0.23–0.89, p = 0.021 for patients with pneumonia).
Conclusion: The frequency of PE and a concomitant disease that can mimic PE was low. The presence of an acute cardiac
disorder or pneumonia was associated with decreased odds of PE.
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Introduction
Acute pulmonary embolism (PE) is a disease that can frequently
cause dyspnea, chest pain, fainting, and hemoptysis [1], and can
be mimicked by other pulmonary and cardiac diseases. Its annual
incidence is approximately 3 to 6 cases per 10,000 persons in the
general population, and the case fatality rate ranges from less than
1% to 60% [2,3,4]. Validated clinical decision rules help to
estimate pretest probability, and PE can be safely excluded in
patients with low to intermediate probability for PE, but without
elevated D-dimers [5,6,7]. Although there is evidence of a raised
risk for PE in hospitalized patients with heart failure and in
patients with a recent respiratory infection [8,9], little is known
about the presence of concomitant PE in patients presenting at the
emergency department (ED) with an acute cardiac disorder or
with pneumonia. This information could help physicians to
estimate the pretest probability of PE in patients in whom a disease
that may cause the patient’s symptoms has already been found, but
where concomitant PE is still suspected. In these situations, clinical
arguments gain additional importance, because D-dimers are
often elevated due to pneumonia or heart failure, and may not be
useful in excluding the presence of concomitant PE [10]. The aim
of this study was to determine the frequency of patients with PE
diagnosed by computed tomography pulmonary angiography
(CTPA) who also had radiological evidence of another chest
disease than PE, to determine the frequency of patients with
concomitant presence of PE and pneumonia or an acute cardiac
disorder, and to compare the proportion of CTPAs with evidence
of PE in patients suffering from pneumonia or an acute cardiac
disorder with patients who received a CTPA, but who did not
suffer from these diseases.
Methods
Patients
For our retrospective analysis, we included all patients aged
$16 years, who received CTPA to exclude or confirm PE at the
ED of a tertiary care hospital, caring for about 30,000 patients per
year, from January 2008 through to May 2012. At our ED, every
decision to perform a CTPA has to be discussed with a senior
physician. A senior physician is always present at the ED, even at
night and during the weekend. CTPAs can be performed 24 hours
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a day 7 days a week, and a radiologist is always present. All
CTPAs were included, regardless of other additional reasons for
the same computed tomogram (CT) (e.g. consequences of trauma,
suspected pulmonary diseases, cancer, or aortic dissection). For all
patients who received a CTPA in the study period, the patient’s
characteristics and the diagnosis at discharge from the emergency
department were identified in our internal database. To estimate
the patient’s pretest probabilities for PE before CTPA, the
simplified revised Geneva score [6] (see Table S1) was calculated
retrospectively.
All patients were examined with a 16-row CT system
(Somatom Sensation 16, Siemens, Forchheim, Germany). All
CTPAs were reviewed by at least two radiologists, one of them
a board certified radiologist with a minimum of 5 years of
experience with CTPA. To measure D-dimers, the enzyme-
linked fluorescent immunoassay VIDAS (bioMe´rieux, Marcy
l’Etoile, France) was used, with a cutoff value of 500 ng/mL.
PE was defined as evidence of filling defects anywhere in the
pulmonary arteries, from the pulmonary trunk down to the first
subsegmental level in at least two 1.5 mm thick transverse
images in CTPA. CT evidence of chest disease other than PE
in CTPA was defined as follows: pulmonary or mediastinal
nodules or mass (by definition, larger than 1 cm), consolidation
or atelectasis with evidence of enhancing pulmonary arteries
(i.e., not attributable to PE or pulmonary infarction), pleural
disease including significant effusion .1 cm that was not
attributable to PE, signs of left ventricular heart failure
(interstitial or alveolar pulmonary edema, pleural effusion and
dilated left ventricle), diseases of the aorta, and evidence of
significant skeletal disease (i.e. fracture, infection, or metastatic
disease). Patients were allocated to the pneumonia group, to the
acute cardiac disorder group, and to the comparison group.
Pneumonia was defined as evidence of clinical signs and
symptoms of pneumonia and evidence of infiltrate in CT that
was not attributable to pulmonary infarction due to PE, and
a final diagnosis of pneumonia was made before leaving the
ED. An acute cardiac disorder was defined as the diagnosis
before leaving the ED of acute coronary syndrome (ACS), acute
left ventricular failure or cardiogenic shock, or tachyarrhythmia.
ACS was defined as the presence of clinical and electrocardio-
graphic signs of myocardial ischemia, and evidence of a culprit
lesion in coronary angiography. Left ventricular failure was
defined as acute or worsening clinical signs and symptoms of
heart insufficiency and evidence of pulmonary edema, pleural
effusion or enlargement of the left atrium or ventricle in CT.
Cardiogenic shock was defined as clinical signs of cardiogenic
shock and echocardiographic signs of left ventricular heart
failure. Tachyarrhythmia was defined as electrocardiographic
evidence of supraventricular tachycardia, tachycardic atrial
fibrillation, tachycardic atrial flutter, ventricular tachycardia, or
ventricular fibrillation. All patients who failed to meet the
criteria of pneumonia or acute cardiac disorder were allocated
to the comparison group.
Statistical Analysis
Statistical analysis was performed by an independent statisti-
cian. Statistical package R (The R Foundation for Statistical
Computing Version 2.12.2) was used. Descriptive statistics
between study groups comprised counts and percentages for
categorical variables and median with interquartile range (IQR)
for the non-normally distributed age values. P values for
categorical variables were calculated by Chi-square tests. P values
for age were determined by using the Kruskal-Wallis test.
Adjusting for multiple comparisons was performed. Logistic
regression was used to compare the proportion of CTPAs with
evidence of PE of patients with pneumonia and with an acute
cardiac disorder to the proportion of CTPAs with evidence of PE
in CTPAs of the comparison group. A difference with a p value of
,0.05 was considered to be significant. Significance was adjusted
for risk factors for thromboembolism (i.e. age, sex, surgery during
the previous month, hospitalization during the previous month,
active cancer, history of thromboembolism, tachycardia, signs of
deep venous thrombosis, hemoptysis, intake of oral contraceptives
[11], and current autoimmune disorder [12]), for low or
intermediate pretest probability but not measured D-dimers, and
for ordering CTPAs to evaluate the patient for PE only and not for
additional chest pathologies.
Ethical Statement
The study was performed according to the convention of
Helsinki, and was approved by the institutional review board, that
waived the need for the patient’s informed consent.
Results
During four years and five months, 1275 CTPAs were
performed in patients from the ED. One hundred sixteen (9%)
patients were referred by a primary or secondary hospital, and of
these, 68 (5%) patients have been hospitalized in the other hospital
prior to referral to our ED. The patients’ characteristics are shown
in Table 1. One thousand two hundred and forty-nine (98%) cases
had low or intermediate pretest probability for PE, and in 504
(40%) cases with low or intermediate pretest probability, D-dimers
were not elevated (n = 69), or not measured (n= 435). Thus, 771
(60%) cases had a definite indication for CTPA.
Two hundred and two (16%) CTPAs contained evidence of
PE. Seven (3%) patients were treated by surgical removal of the
embolus, and 14 (7%) received lytic therapies. In 28 (2.2%)
CTPAs, there was concomitant presence of PE and radiological
evidence of another chest disease, and in 3 more cases (0.2%),
there was concomitant presence of PE and an acute cardiac
disorder without radiological evidence of heart failure (Table 2).
Of 113 patients who suffered from pneumonia, 11 (10%) had
concomitant PE. Of 154 patients who suffered from an acute
cardiac disorder, only five (3.3%) had concomitant PE. Of the
1008 remaining patients of the comparison group who received
a CTPA, 186 (18%) had PE (Figure 1). Table 3 outlines the
frequencies of PE for pretest probabilities (i.e. low, intermediate,
high) in the different groups. After adjustment for risk factors
for thromboembolism, for low or intermediate pretest probabil-
ity but not measured D-dimers, and for ordering CTPAs to
evaluate the patient for PE only and not for additional chest
pathologies, the proportions of CTPAs with evidence of PE in
patients with an acute cardiac disorder or pneumonia was
significantly lower than in the comparison group (OR 0.13,
95% CI 0.05–0.33, p,0.001 for patients with an acute cardiac
disorder, and OR 0.45, 95% CI 0.23–0.89, p = 0.021 for
patients with pneumonia.
Discussion
In our study, only 2.2% of 1275 patients admitted to the ED,
who received a CTPA, had radiological evidence of a concomitant
disease in addition to PE, and 2.4% of all patients had evidence of
a concomitant disease in CTPA or an acute cardiac disorder in
addition to PE. The presence of a disease that could mimic the
symptoms of PE, such as an acute cardiac disorder or pneumonia,
was associated with decreased odds of PE. In contrast to the
Cardiac Disorder or Pneumonia, and PE
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comparison group, the frequency of PE in patients with acute
cardiac disorder or pneumonia was low throughout all pretest
probabilities (Table 3).
It has been shown, that acute infection and recent respiratory
infection, and raised inflammatory markers, are associated with
increased odds of thromboembolic disease [9,13,14]. In one study,
pneumonia was associated with PE (adjusted OR=2.38, 95% CI
1-13-4.99) [9]. However, in that study, patients were analyzed five
to 52 weeks after pneumonia, and not during acute infection. In
another study, there was evidence of a relative risk of 2.15 (95% CI
2.15–2.16) for PE for hospitalized patients with heart failure,
compared with patients without heart failure [8]. However, the
prevalence of thromboembolism in patients with an acute heart
disorder presenting to the ED is unknown. On the other hand, in
the analysis of the outpatient and inpatient population with
suspected PE, from which the Wells-score was derived, the
possibility of a diagnosis other than PE was associated with
decreased odds of PE [5], which is in line with our findings. In our
study, 95% of the patients have been admitted from home. In
these patients, our findings suggest that the obvious presence of
a disease that could mimic the symptoms of PE makes
a concomitant presence of PE unlikely. This could help to decide
when to order a CTPA, particularly in patients with low or
intermediate probability, as estimated by validated scores, and
with elevated D-dimers.
Our study has several limitations. First, it was a retrospective
analysis of a selected group of patients who received a CTPA
ordered by physicians of the ED to confirm or rule out PE.
However, this reflects a ‘‘real world’’ selection of patients
presenting at our ED. Second, this investigation was a single
centre study. In 40% of cases with low or intermediate pretest
probability for PE, the D-dimers were not elevated or this test was
Table 1. Characteristics of Patients.
Pneumonia group P value*
Acute cardiac
disorder group P value{ Comparison group
n=113 n=154 n=1008
Age, median (IQR) 62 (45–73) 0.97 70 (59–77) ,0.001 63 (49–73)
Age .65 years, n (%) 53 (47) 0.45 93 (60) ,0.001 430 (43)
Male sex, n (%) 63 (56) 0.69 94 (61) 0.3 537 (53)
Sign of deep vein thrombosis{, n (%) 3 (3) 0.1 7 (5) 0.14 90 (9)
Cancer, n (%) 27 (24) 0.043 14 (9) 0.043 158 (16)
Tachycardia1, n (%) 48 (42) ,0.001 76 (49) ,0.001 247 (25)
Hemoptysis, n (%) 8 (7) 0.04 2 (1) 0.42 29 (3)
History of thromboembolism, n (%) 13 (12) 1 13 (8) 0.8 114 (11)
Surgery||, n (%) 3 (3) 0.64 6 (4) 0.64 59 (6)
Hospitalization", n (%) 11 (10) 0.89 11 (7) 0.96 77 (8)
Autoimmune disorder, n (%) 11 (10) 0.041 3 (2) 0.21 45 (4)
Oral contraceptives, n (%) 2 (2) 1 2 (1) 1 23 (2)
Cardiac arrest/CPR, n (%) 0 (0) 0.11 20 (13) ,0.001 29 (3)
Evaluating for PE only**, n (%) 48 (43) 0.01 92 (60) 0.65 579 (57)
Referred by another hospital 13 (12) 0.58 17 (11) 0.58 86 (9)
Pretest probability{{
Low (0–1 points), n (%) 36 (32) 0.032 44 (29) 0.002 440 (44)
Intermediate (2–4 points), n (%) 74 (66) 0.049 106 (69) 0.003 549 (55)
High (.4 points), n (%) 3 (3) 0.8 4 (3) 0.8 19 (2)
Low/Intermediate, D-dimers not
elevated{{, n (%) 4 (4) 0.58 4 (3) 0.36 61 (6)
Low/Intermediate, D-dimers not
measured, n (%) 55 (49) 0.001 59 (38) 0.13 321 (32)
Pneumonia was defined as evidence of clinical signs and symptoms of pneumonia and evidence of infiltrate in CTPA that was not attributable to pulmonary infarction
due to PE, and a final diagnosis of pneumonia before leaving the ED. An acute cardiac disorder was defined as the diagnosis of acute coronary syndrome, confirmed by
coronary angiography (ACS), acute left ventricular failure or cardiogenic shock, or tachyarrhythmia before leaving the ED. All patients who failed to meet the criteria of
pneumonia or acute cardiac disorder were allocated to the comparison group. IQR denotes interquartile range. CPR denotes cardiopulmonary resuscitation.
*Pneumonia group vs. comparison group;
{acute cardiac disorder group vs. comparison group;
{pain or swelling of a limb;
1$100 beats/minute;
||history of surgery during previous month;
"history of hospitalization during previous month;
**CTPAs that was ordered to evaluate the patient for PE only and not for an additional disease such as consequences of trauma, suspected pulmonary disease, cancer or
aortic dissection;
{{estimated by using simplified revised Geneva score (see Table S1);
{{,500 ng/mL.
doi:10.1371/journal.pone.0047418.t001
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not performed, even though, in 2010, all physicians received
training in diagnosing PE using the Wells score and the simplified
revised Geneva score in combination with the D-dimer test and
CTPA. This is comparable to a multicenter study, where in one
third of patients with Wells score ,6 points - indicating low or
intermediate pretest probability for PE-, the D-dimer test was
negative or not performed, and CTPA was potentially avoidable
[15]. Thus, the behavior of physicians of our ED in using
guidelines might be comparable to physicians in other EDs. We
note that in a survey performed in 2010 to 2011 at our ED,
physicians declared that about one half of CTPAs were not only
ordered out of adherence to evidence based decision rules, but also
out of ‘‘fear of missing PE’’ [16]. It is not known if physicians of
other EDs have similar motivations for ordering radiologic tests,
and, therefore, the possibility of generalizing this present study
might be limited.
Third, an acute cardiac disorder is more strongly associated
with decreased odds of PE than is the presence of pneumonia. We
cannot determine whether this was due to the selection bias in
patients to receive a CTPA or due to a true elevated risk for PE in
patients with pneumonia compared to patients with an acute
cardiac disorder.
Fourth, to estimate the pretest probability retrospectively, we
used the revised simplified Geneva score, which is normally used
at our ED, although the prevalence of PE in our patients was lower
than in the population from which the revised simplified Geneva
score was derived (16% vs. 23%). Thus, the estimation of pretest
probability might not have been exact. Therefore, we adjusted the
significance of the results for the different risk factors for
thromboembolism, and not for pretest probability. We could not
use the Wells score, because it is not possible to determine the
variable ‘‘an alternative diagnosis is less likely than PE’’
retrospectively.
Finally, we did not perform a follow up. Thus, we are not
able to determine the number of patients with a negative CTPA
who developed PE after discharge from the ED. However,
a metaanalysis with patients with negative CTPA who did not
receive anticoagulation showed a 3-month rate of subsequent
thromboembolism of 1.4%, and a 3-month rate of fatal PE of
0.51% [17], which is similar to the results after a normal
Figure 1. Frequencies of PE in patients with pneumonia, acute cardiac disorder, and in patients of the comparison group. CTPA
denotes computed tomography pulmonary angiography. PE denotes acute pulmonary embolism. ACS, not confirmed denotes suspected acute
coronary syndrome that was not confirmed by coronary angiography. Patients in the comparison group had either PE or one of the listed diagnoses
at discharge from the emergency department. *Other: empyema, hematoma, leg pain or leg swelling of unknown origin, nephrotic syndrome,
pneumothorax, obesity hypoventilation syndrome, sickle cell crisis, sinusitis, tuberculosis, malaise of unknown origin, fever of unknown origin,
paralysis, elevated D-dimers of unknown origin, hemoptysis of unknown origin, cough of unknown origin, epiglottitis, hepatic encephalopathy, coma
of unknown origin, anemia, ketoacidosis, anaphylactic reaction, struma, intoxication, spondylodiscitis, sternum infection, knee arthritis.
doi:10.1371/journal.pone.0047418.g001
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invasive pulmonary angiogram [18]. All studies of this
metaanalysis used early-generation CT technology. Thus, an
even lower rate of subsequent thromboembolism might be
expected after CTPAs performed with a 16-row CT system that
is available at our institution.
In conclusion, the frequency of the concomitant presence of PE
and another disease that can mimic the symptoms of PE was low
in patients who were selected to receive a CTPA at our ED. The
presence of pneumonia or, most notably, an acute cardiac
disorder, was associated with decreased odds of PE. Our results
could further encourage physicians to avoid ordering unnecessary
CTPAs.
Supporting Information
Table S1 Simplified Revised Geneva Score. Simplified
Revised Geneva Score: 0–1 points indicates low (8%), 2–4 points
intermediate (29%), and $5 points high (64%) pretest probability
for PE. DVT denotes deep vein thrombosis, PE denotes
pulmonary embolism.
(DOCX)
Acknowledgments
We thank Urs Simmen PhD, Statistical Consulting, Basel, Switzerland, for
statistical analysis, and Rodney Yeates PhD for reviewing the manuscript.
Author Contributions
Conceived and designed the experiments: MR AE HZ ZSF. Performed the
experiments: MR. Analyzed the data: MR AE HZ ZSF CAP. Contributed
reagents/materials/analysis tools: MR HZ ZSF AE. Wrote the paper: MR
AE HZ ZSF.
References
1. Miniati M, Cenci C, Monti S, Poli D (2012) Clinical presentation of acute
pulmonary embolism: survey of 800 cases. PLoS One 7: e30891.
2. Oger E (2000) Incidence of venous thromboembolism: a community-based study
in Western France. EPI-GETBP Study Group. Groupe d’Etude de la
Thrombose de Bretagne Occidentale. Thromb Haemost 83: 657–660.
3. Spencer FA, Emery C, Lessard D, Anderson F, Emani S, et al. (2006) The
Worcester Venous Thromboembolism study: a population-based study of the
clinical epidemiology of venous thromboembolism. J Gen Intern Med 21: 722–
727.
4. Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical
outcomes in the International Cooperative Pulmonary Embolism Registry
(ICOPER). Lancet 353: 1386–1389.
5. Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, et al. (2000)
Derivation of a simple clinical model to categorize patients probability of
pulmonary embolism: increasing the models utility with the SimpliRED D-
dimer. Thromb Haemost 83: 416–420.
6. Klok FA, Mos IC, Nijkeuter M, Righini M, Perrier A, et al. (2008) Simplification
of the revised Geneva score for assessing clinical probability of pulmonary
embolism. Arch Intern Med 168: 2131–2136.
7. Carrier M, Righini M, Djurabi RK, Huisman MV, Perrier A, et al. (2009)
VIDAS D-dimer in combination with clinical pre-test probability to rule out
pulmonary embolism. A systematic review of management outcome studies.
Thromb Haemost 101: 886–892.
8. Beemath A, Stein PD, Skaf E, Al Sibae MR, Alesh I (2006) Risk of venous
thromboembolism in patients hospitalized with heart failure. Am J Cardiol 98:
793–795.
9. Clayton TC, Gaskin M, Meade TW (2011) Recent respiratory infection and risk
of venous thromboembolism: case-control study through a general practice
database. Int J Epidemiol 40: 819–827.
10. Kelly J, Rudd A, Lewis RR, Hunt BJ (2002) Plasma D-dimers in the diagnosis of
venous thromboembolism. Arch Intern Med 162: 747–756.
11. Goldhaber SZ, Bounameaux H (2012) Pulmonary embolism and deep vein
thrombosis. Lancet 379: 1835–1846.
12. Zoller B, Li X, Sundquist J, Sundquist K (2012) Risk of pulmonary embolism in
patients with autoimmune disorders: a nationwide follow-up study from Sweden.
Lancet 379: 244–249.
13. Schmidt M, Horvath-Puho E, Thomsen RW, Smeeth L, Sorensen HT (2012)
Acute infections and venous thromboembolism. J Intern Med 271: 608–618.
14. Matos MF, Lourenco DM, Orikaza CM, Bajerl JA, Noguti MA, et al. (2011)
The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6-
174GC, IL-8-251AT and MCP-1-2518AG in the risk of venous thromboem-
bolism: a case-control study. Thromb Res 128: 216–220.
15. Venkatesh AK, Kline JA, Courtney DM, Camargo CA, Plewa MC, et al. (2012)
Evaluation of Pulmonary Embolism in the Emergency Department and
Consistency With a National Quality Measure: Quantifying the Opportunity
for ImprovementEvaluation of Pulmonary Embolism in ER. Arch Intern Med:
1–5.
16. Rohacek M, Buatsi J, Szucs-Farkas Z, Kleim B, Zimmermann H, et al. (2012)
Ordering CT pulmonary angiography to exclude pulmonary embolism: defense
versus evidence in the emergency room. Intensive Care Med 38: 1345–1351.
17. Moores LK, Jackson WL, Jr., Shorr AF, Jackson JL (2004) Meta-analysis:
outcomes in patients with suspected pulmonary embolism managed with
Table 2. Cases of concomitant presence of PE and another
disease that could mimic PE.
n=
Evidence of chest disease in CTPA
CAP* 10
P.jirovecii pneumonia 1
Metastatic cancer 3
Relapsing AML with lymphadenopathy 1
Emphysema 5
Granulomatous pneumopathy 1
Chronic aspergilloma 1
Pulmonary laceration/rib fracture after trauma 1
Serothorax after pneumonectomy 1
Pulmonary hypertension due to HIV infection 1
Acute heart failure 1
Cardiogenic shock due to ACS 1
Spondylodiscitis 1
Cardiac disorder without evidence in CTPA
STEMI 2
New onset of tachycardic atrial fibrillation 1
PE denotes pulmonary embolism. CTPA denotes computed tomography
pulmonary angiography. CAP denotes community acquired pneumonia. AML
denotes acute myeloid leukemia. ACS denotes acute coronary syndrome. STEMI
denotes ST-elevation myocardial infarction.
*includes one case of Mycoplasma pneumonia infection with hemolytic anemia.
doi:10.1371/journal.pone.0047418.t002
Table 3. Frequencies of PE.
Groups Pretest probability for PE
Low Intermediate High
All (n = 1275) 52/520 (10%) 143/729 (20%) 7/26 (27%)
Pneumonia (n = 113) 3/36 (8%) 8/74 (11%) 0/3 (0%)
Acute cardiac disorder
(n = 154)
1/44 (2%) 4/106 (4%) 0/4 (0%)
Comparison group
(n = 1008)
48/440 (11%) 131/549 (24%) 7/19 (37%)
PE denotes acute pulmonary embolism. To estimate pretest probabilities, the
simplified revised Geneva score was used (low probability: ,2 points;
intermediate probability: 2 to 4 points; high probability: .5 points, see Table
S1).
doi:10.1371/journal.pone.0047418.t003
Cardiac Disorder or Pneumonia, and PE
PLOS ONE | www.plosone.org 5 October 2012 | Volume 7 | Issue 10 | e47418
computed tomographic pulmonary angiography. Ann Intern Med 141: 866–
874.
18. van Beek EJ, Brouwerst EM, Song B, Stein PD, Oudkerk M (2001) Clinical
validity of a normal pulmonary angiogram in patients with suspected pulmonary
embolism–a critical review. Clin Radiol 56: 838–842.
Cardiac Disorder or Pneumonia, and PE
PLOS ONE | www.plosone.org 6 October 2012 | Volume 7 | Issue 10 | e47418
